{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:27:06Z","timestamp":1776482826117,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","issue":"31-32","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.vaccine.2004.04.030","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T20:23:03Z","timestamp":1086812583000},"page":"4332-4341","source":"Crossref","is-referenced-by-count":65,"title":["Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice"],"prefix":"10.1016","volume":"22","author":[{"given":"P. Patrick","family":"Cleary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yury V.","family":"Matsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thu","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Olmsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.04.030_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00006454-199704000-00012","article-title":"Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease","volume":"16","author":"Veasy","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2004.04.030_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1099\/00222615-39-3-165","article-title":"The serotypes of Streptococcus pyogenes present in Britain during 1980\u20131990 and their association with disease","volume":"39","author":"Colman","year":"1993","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2004.04.030_bib3","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1542\/peds.108.5.1180","article-title":"Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group a streptococci from children with acute pharyngitis","volume":"108","author":"Kaplan","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2004.04.030_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00006454-199406000-00036","article-title":"Treatment failures and carriers: perception of problems?","volume":"13","author":"Gerber","year":"1994","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2004.04.030_bib5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00005537-199705000-00016","article-title":"Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis","volume":"107","author":"\u00d6sterlund","year":"1997","journal-title":"Laryngoscope"},{"key":"10.1016\/j.vaccine.2004.04.030_bib6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1365-2958.2001.02563.x","article-title":"Horizontal gene transfer and host specificity of beta-haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb","volume":"41","author":"Franken","year":"2001","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.vaccine.2004.04.030_bib7","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1128\/IAI.60.5.1890-1893.1992","article-title":"Evidence consistent with horizontal transfer of the gene (emm12) encoding serotype M12 protein between group A and group G pathogenic streptococci","volume":"60","author":"Simpson","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.030_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/IAI.64.2.503-510.1996","article-title":"C5a peptidase alters clearance and trafficking of group A streptococci by infected mice","volume":"64","author":"Ji","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.030_bib9","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1128\/IAI.66.11.5399-5405.1998","article-title":"Impact of M49, Mrp, Enn, and C5a peptidase proteins on colonization of the mouse oral mucosa by Streptococcus pyogenes","volume":"66","author":"Ji","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.030_bib10","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1128\/IAI.65.6.2080-2087.1997","article-title":"Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A streptococcus","volume":"65","author":"Ji","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.030_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/infdis\/163.1.109","article-title":"The human antibody response to streptococcal C5a peptidase","volume":"163","author":"O\u2019Connor","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.04.030_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0140-6736(92)90339-5","article-title":"Clonal basis for resurgence of serious streptococcal disease in the 1980\u2019s","volume":"321","author":"Cleary","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.04.030_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/377700","article-title":"The immune response to group A streptococcal C5 peptidase in children: implications for vaccine development","volume":"188","author":"Shet","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.04.030_bib14","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1128\/IAI.66.10.4593-4601.1998","article-title":"Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells","volume":"66","author":"Cue","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.030_bib15","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/IAI.63.3.994-1003.1995","article-title":"Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease","volume":"63","author":"Musser","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.030_bib16","first-page":"350","article-title":"M+ group A streptococci are phagocytized and killed in whole blood by C5a activated PMNs","volume":"69","author":"DeMaster","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.030_bib17","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1046\/j.1432-1033.2002.03183.x","article-title":"Processing, stability, and kinetic parameters of C5a peptidase from Streptococcus pyogenes","volume":"269","author":"Anderson","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.vaccine.2004.04.030_bib18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2144\/97234bm01","article-title":"Modification of a PCR-based site-directed mutagenesis method","volume":"23","author":"Fisher","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2004.04.030_bib19","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1128\/IAI.70.11.6409-6415.2002","article-title":"Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice","volume":"70","author":"Cheng","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.030_bib20","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/JB.182.11.3254-3258.2000","article-title":"Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate","volume":"182","author":"Stafslien","year":"2000","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.vaccine.2004.04.030_bib21","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1128\/IAI.70.5.2408-2413.2002","article-title":"The group B streptococcal C5a peptidase is both a specific protease and an invasin","volume":"70","author":"Cheng","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.030_bib22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/978-1-4899-1825-3_178","article-title":"Structural and functional similarity of C5a-ase enzymes from group A and B streptococci","volume":"418","author":"Chmouryguina","year":"1997","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.vaccine.2004.04.030_bib23","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/S0021-9258(19)39748-0","article-title":"Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes","volume":"265","author":"Chen","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2004.04.030_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00006454-198507000-00008","article-title":"Acquisition of group A streptococcal M protein antibodies","volume":"4","author":"Quinn","year":"1985","journal-title":"Pediatr. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.04.030_bib25","series-title":"Rheumatic fever","first-page":"41","article-title":"Epidemiology of streptococcal pharyngitis, rheumatic fever, and rheumatic heart disease","author":"Kumar","year":"1999"},{"key":"10.1016\/j.vaccine.2004.04.030_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5694\/j.1326-5377.1996.tb122012.x","article-title":"Acute rheumatic fever and rheumatic heart disease in the top end of Australia\u2019s Northern Territory","volume":"164","author":"Carapetis","year":"1996","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.vaccine.2004.04.030_bib27","unstructured":"The World Health Report, Office of World Health Reporting. World Health Organization, Geneva, 1998."},{"key":"10.1016\/j.vaccine.2004.04.030_bib28","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4049\/jimmunol.171.5.2532","article-title":"M cells in nasal-associated tissue: a portal of entry for the respiratory mucosal pathogen Group A streptococcus","volume":"171","author":"Park","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.04.030_bib29","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1128\/JCM.34.10.2511-2515.1996","article-title":"M proteins of group C streptococci isolated from patients with acute pharyngitis","volume":"34","author":"Bisno","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2004.04.030_bib30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1086\/515241","article-title":"Role of emm and mrp genes in the virulence of group A streptococcal isolate 64\/14 in a mouse model of skin infection","volume":"177","author":"Boyle","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.04.030_bib31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/IAI.55.3.753-757.1987","article-title":"M proteins of group G streptococci isolated from bacteremic human infections","volume":"55","author":"Bisno","year":"1987","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.030_bib32","series-title":"Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions","author":"Fischetti","year":"1991"},{"key":"10.1016\/j.vaccine.2004.04.030_bib33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(94)92083-4","article-title":"Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci","volume":"344","author":"Pruksakorn","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.04.030_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0264-410X(98)00150-9","article-title":"Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments","volume":"17","author":"Dale","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.04.030_bib35","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.4049\/jimmunol.141.10.3551","article-title":"Group B streptococci inhibit the chemotactic activity of the fifth component of complement","volume":"141","author":"Hill","year":"1988","journal-title":"J. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04003755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04003755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T20:46:12Z","timestamp":1682714772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04003755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":35,"journal-issue":{"issue":"31-32","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0264410X04003755"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.04.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}